Neurodevelopment in the First 2 Years of Life Following Prenatal Exposure to Maternal SARS-CoV-2 Infection
JAMA Network Open · 07.11.2024 · 7 (11) · e2443697
DOI: 10.1001/jamanetworkopen.2024.43697 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 07.11.2024. Verfasst von Daphne M Vrantsidis und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Prenatal Exposure Delayed Effects, Neurodevelopmental Disorders, Maternal Exposure, COVID-19. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.
Abstract (Originalsprache)
Importance The effects of prenatal exposure to SARS-CoV-2 infection on child development throughout the first 2 years of life are unknown.
Objective
To evaluate whether prenatal exposure to SARS-CoV-2 infection was associated with child neurodevelopmental outcomes during the first 2 years of life. Design, Setting, and Participants This cohort study used data from the longitudinal, population-based pan-Canadian Pregnancy During the COVID-19 Pandemic cohort, which recruited participants from April 2020 to July 2022. Children were categorized as exposed to prenatal SARS-CoV-2 infection if their birthing parent had a positive polymerase chain reaction test performed by a health authority or as a healthy negative comparison if their birthing parent did not have SARS-CoV-2 antibodies in their postpartum dried blood spot sample. Exposure Prenatal SARS-CoV-2 infection. Main Outcomes and Measures The birthing parent reported on their child’s temperament at ages 6 and 24 months, developmental milestones at ages 12 and 24 months, and social-emotional milestones at ages 12 and 24 months.
Results
A total of 896 children were included, with 96 children who had been exposed to a prenatal SARS-CoV-2 infection (mean [SD] gestational age at birth, 39.20 [1.50] weeks; 45 [47%] male) and 800 were healthy negative comparisons (mean [SD] gestational age at birth, 39.47 [1.54] weeks; 388 [49%] male). In analyses of covariance adjusted for prepregnancy medical conditions and household socioeconomic status, prenatal exposure to SARS CoV-2 infection was associated with slightly higher regulatory control scores, indicating more regulation, at age 6 months (difference in means, 0.19 [95% CI, 0.02-0.36]; P = .03; η p 2 = 0.01). No significant differences were observed for the other neurodevelopmental outcomes. In mixed models adjusted for the same covariates that aimed to examine change in outcomes over time, prenatal SARS-CoV-2 infection exposure was not associated with developmental change in any neurodevelopmental outcomes between ages 6 and 24 months. Conclusions and Relevance In this longitudinal cohort study of multiple aspects of child neurodevelopment between ages 6 and 24 months, negligible associations between prenatal exposure to SARS-CoV-2 infection and child outcomes were observed. Follow-up research is warranted to determine whether these predominantly null effects persist into later childhood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.
- Alberta Children's Hospital Research Institute (ACHRI), Calgary, Alberta, Canada.
- Department of Obstetrics & Gynecology, University of Calgary, Calgary, Alberta, Canada.
- Department of Interdisciplinary Human Sciences, Texas Tech University, Lubbock.
- Institute of Medical Psychology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
- Institute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
Förderung
- CIHR
Zitieren
APA
Vrantsidis, D. M., van de Wouw, M., Hall, E. R. M., Kuret, V., Rioux, C., Conrad, M. L., Mesa, C., Harris, A., Lebel, C., Tomfohr-Madsen, L., & Giesbrecht, G. F. (2024). Neurodevelopment in the First 2 Years of Life Following Prenatal Exposure to Maternal SARS-CoV-2 Infection. JAMA Network Open, 7(11), e2443697. https://doi.org/10.1001/jamanetworkopen.2024.43697
Vancouver
Vrantsidis DM, van de Wouw M, Hall ERM, Kuret V, Rioux C, Conrad ML, et al. Neurodevelopment in the First 2 Years of Life Following Prenatal Exposure to Maternal SARS-CoV-2 Infection. JAMA Network Open. 2024;7(11):e2443697. doi:10.1001/jamanetworkopen.2024.43697
BibTeX
@article{Vrantsidis2024,
author = {Vrantsidis, Daphne M and van de Wouw, Marcel and Hall, Emily R M and Kuret, Verena and Rioux, Charlie and Conrad, Melanie L and Mesa, Christine and Harris, Angela and Lebel, Catherine and Tomfohr-Madsen, Lianne and Giesbrecht, Gerald F},
title = {Neurodevelopment in the First 2 Years of Life Following Prenatal Exposure to Maternal SARS-CoV-2 Infection},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {11},
pages = {e2443697},
doi = {10.1001/jamanetworkopen.2024.43697}
}
EUVIMED